X4 Pharmaceuticals (XFOR) Current Leases (2019 - 2025)

X4 Pharmaceuticals' Current Leases history runs 7 years deep, the most recent figure standing at $994000.0 for Q4 2025.

• Quarterly Current Leases fell 20.54% year-over-year to $994000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $994000.0 (down 20.54% YoY) and the FY2025 annual result came in at $994000.0, down 20.54% from the prior year.
• Current Leases was $994000.0 for Q4 2025 at X4 Pharmaceuticals, down from $1.2 million in the prior quarter.
• Across five years, Current Leases topped out at $1.4 million in Q2 2025 and bottomed at $875000.0 in Q1 2021.
• A 5-year average of $1.1 million and a median of $1.1 million in 2022 frame the typical range for Current Leases.
• Annual changes were most pronounced in 2021 — Current Leases surged 37.7% — and 2025, when it retreated 20.54%.
• X4 Pharmaceuticals' Current Leases stood at $1.1 million in 2021, then advanced by 11.44% to $1.2 million in 2022, then retreated by 8.26% to $1.1 million in 2023, then climbed by 13.83% to $1.3 million in 2024, then retreated by 20.54% to $994000.0 in 2025.
• Business Quant data shows XFOR's Current Leases at $994000.0 in Q4 2025, $1.2 million in Q3 2025, and $1.4 million in Q2 2025.